This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Upbound Group (UPBD) Soars 8.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Upbound Group (UPBD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UPBDPositive Net Change MGRCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Fastly (FSLY) Soars 13.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Fastly (FSLY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
FSLYPositive Net Change LAWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ams-OSRAM AG Unsponsored ADR (AMSSY) Soars 13.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
ams-OSRAM AG Unsponsored ADR (AMSSY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AMSSYNo Net Change AXTINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Teekay Tankers (TNK) Soars 7.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Teekay Tankers (TNK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TNKNegative Net Change GNKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Webtoon (WBTN) Soars 5.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Webtoon (WBTN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
WBTNNegative Net Change AFRMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Monte Rosa Therapeutics (GLUE) Soars 44.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Monte Rosa Therapeutics (GLUE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
GLUEPositive Net Change DAWNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Seagate (STX): Can Its 7.7% Jump Turn into More Strength?
by Zacks Equity Research
Seagate (STX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
STXNegative Net Change IONQNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
California Resources (CRC) Soars 6.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
California Resources (CRC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
CRCPositive Net Change WTIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Pyxis Oncology, Inc. (PYXS) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PYXSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Howard Hughes Holdings (HHH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HHHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in Medical Properties (MPW): Can Its 11.3% Jump Turn into More Strength?
by Zacks Equity Research
Medical Properties (MPW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions could translate into further price increase in the near term.
MPWPositive Net Change STAGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Century (CENX) Moves 6.4% Higher: Will This Strength Last?
by Zacks Equity Research
Century (CENX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
CENXPositive Net Change TRSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Rambus (RMBS) Surges 14.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Rambus (RMBS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RMBSPositive Net Change LRCXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
DNOW (DNOW) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
DNOWPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Photronics (PLAB) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
PLABNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Offerpad Solutions (OPAD) Surges 29.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Offerpad Solutions (OPAD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OPADPositive Net Change NMRKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lifecore Biomedical (LFCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
LFCRPositive Net Change ALECPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar?
by Zacks Equity Research
Tempus (TEM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TEMPositive Net Change OMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Silicon Motion (SIMO): Can Its 6.4% Jump Turn into More Strength?
by Zacks Equity Research
Silicon Motion (SIMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SIMOPositive Net Change MUPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Thor Industries (THO) Moves 3.2% Higher: Will This Strength Last?
by Zacks Equity Research
Thor Industries (THO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
THOPositive Net Change CVCOPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
PACS Group, Inc. (PACS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PACSPositive Net Change CORPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Micron (MU): Can Its 7.6% Jump Turn into More Strength?
by Zacks Equity Research
Micron (MU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
MUPositive Net Change STXNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Cadence (CDNS) Stock Jumps 4.8%: Will It Continue to Soar?
by Zacks Equity Research
Cadence (CDNS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
CDNSNegative Net Change CVLTPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
NCS Multistage (NCSM) Soars 10.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
NCS Multistage (NCSM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NCSMPositive Net Change RNGRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Crescent Energy (CRGY) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Crescent Energy (CRGY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRGYPositive Net Change CEGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today